
This month, Governor @GregAbbott_TX signed the Texas Cyber Command into law. The Texas Cyber Command will lead the charge to defend Texas’ critical infrastructure from hostile cybersecurity threats.
Market Brief
Daily market recaps with key events, stock movements, and global influences
Texas Gov. Abbott calls special session on flood relief, taxes; signs bill targeting drug ads.
Texas Governor Abbott calls special session starting July 21 on flood relief, taxes, and disaster policyAbbott Calls Texas Special Session on Flood Relief, Taxes, Testing Overhaul
Session agenda includes funding for flood-warning systems and emergency communications after July 4 floodsAbbott Calls Texas Special Session on Flood Relief, Taxes, Testing Overhaul
Lawmakers to consider property tax cuts, elimination of STAAR testing, and restrictions on hemp-derived THC salesAbbott Calls Texas Special Session on Flood Relief, Taxes, Testing Overhaul
Abbott signed 306 new laws, including HB 3441 increasing drug manufacturer liability for deceptive advertising in TexasAbbott Signs 306 Bills, Including Measure Targeting Drug Ads in Texas
New laws mandate efficiency audits of state agencies and expand school safety requirementsAbbott Signs 306 Bills, Including Measure Targeting Drug Ads in Texas
Texas is set for an active legislative period with a special session focused on disaster response and fiscal policy. The immediate driver is the aftermath of severe flooding, which is likely to prompt increased state spending on emergency infrastructure and could impact firms involved in disaster management and insurance.
The session will also revisit tax and regulatory measures. Property tax cuts could influence real estate activity and local government funding, while proposed changes to education and cannabis-related products may affect their respective sectors.
Separately, the new law raising legal exposure for drug manufacturers advertising in Texas (HB 3441) is notable for healthcare and pharma companies with significant state presence, potentially increasing compliance costs and legal risk.
Traders should monitor the legislative developments for sector-specific impacts, particularly in insurance, real estate, healthcare, and consumer products with Texas exposure. Headlines from the session may drive short-term moves in affected names.
Texas Gov. Abbott calls special session on flood relief, taxes; signs bill targeting drug ads.
Texas Governor Abbott calls special session starting July 21 on flood relief, taxes, and disaster policyAbbott Calls Texas Special Session on Flood Relief, Taxes, Testing Overhaul
Session agenda includes funding for flood-warning systems and emergency communications after July 4 floodsAbbott Calls Texas Special Session on Flood Relief, Taxes, Testing Overhaul
Lawmakers to consider property tax cuts, elimination of STAAR testing, and restrictions on hemp-derived THC salesAbbott Calls Texas Special Session on Flood Relief, Taxes, Testing Overhaul
Abbott signed 306 new laws, including HB 3441 increasing drug manufacturer liability for deceptive advertising in TexasAbbott Signs 306 Bills, Including Measure Targeting Drug Ads in Texas
New laws mandate efficiency audits of state agencies and expand school safety requirementsAbbott Signs 306 Bills, Including Measure Targeting Drug Ads in Texas
Texas is set for an active legislative period with a special session focused on disaster response and fiscal policy. The immediate driver is the aftermath of severe flooding, which is likely to prompt increased state spending on emergency infrastructure and could impact firms involved in disaster management and insurance.
The session will also revisit tax and regulatory measures. Property tax cuts could influence real estate activity and local government funding, while proposed changes to education and cannabis-related products may affect their respective sectors.
Separately, the new law raising legal exposure for drug manufacturers advertising in Texas (HB 3441) is notable for healthcare and pharma companies with significant state presence, potentially increasing compliance costs and legal risk.
Traders should monitor the legislative developments for sector-specific impacts, particularly in insurance, real estate, healthcare, and consumer products with Texas exposure. Headlines from the session may drive short-term moves in affected names.
13 posts • OpenAI (o3)
Published
Texas Governor Greg Abbott on Friday signed 306 measures sent to him by the Legislature, capping a flurry of end-of-session activity ahead of Sunday’s deadline to act on remaining bills. His office designated 15 of the newly enacted laws as “critical.”
Among the measures is House Bill 3441, which empowers the state and consumers to sue pharmaceutical companies over deceptive advertising carried in Texas. Abbott earlier this month also approved the creation of the Texas Cyber Command, a new unit charged with protecting the state’s infrastructure from cyberattacks.
Read more
This month, Governor @GregAbbott_TX signed the Texas Cyber Command into law. The Texas Cyber Command will lead the charge to defend Texas’ critical infrastructure from hostile cybersecurity threats.
Featured story, from @KitOConnell: Tomorrow is the deadline for Governor Greg Abbott to sign, veto or let SB 3 become law automatically. One estimate suggests over 50,000 jobs and billions in income are on the line.
Abbott hinted a special session may be needed because the Legislature didn’t pass a ban on cities, counties and school districts hiring lobbyists with taxpayer money to represent them at the...
All Senate Democrats voted against the bill. They support TAXPAYER-FUNDED LOBBYING. All Texas House Republicans should vote for the bill if a special session is called.
And...@GregAbbott_TX just signed HB 3441 into law! It holds BIG PHARMA accountable if they advertise in Texas!! Thank you, Gov!💪💪💪
5 posts • GPT (4.1 mini)
Published
The World Health Organization (WHO) has approved new guidelines regulating the digital marketing of infant formula and other breast milk substitutes. This initiative, led by Brazil and supported by 20 countries, aims to ensure the appropriate use of products targeted at children and to protect parents and babies from misleading online advertisements. The agreement was reached during the 78th World Health Assembly (WHA78), where member countries also endorsed World Prematurity Day as an official WHO health campaign to emphasize the importance of prevention and expanded lifesaving healthcare for premature babies. The expansion of the International Code of Marketing of Breast-milk Substitutes to include digital marketing represents a significant policy advancement in public health efforts for infant nutrition.
9 posts • GPT (4.1 mini)
Published
Abbott Laboratories announced plans to invest $500 million in expanding its U.S. manufacturing capacity amid looming tariffs on medical devices and diagnostics. The company will build two new manufacturing plants located in Illinois and Texas. This expansion is expected to create up to 200 new jobs, particularly in the northern suburbs of Chicago. Despite the anticipated impact of tariffs, which Abbott estimates could reduce earnings by a few hundred million dollars, the company maintained its annual profit forecast. Abbott's investment reflects a strategic response to the evolving trade environment affecting the medical device industry.
25 posts • Grok (2)
Published
Abbott Laboratories reported its first-quarter 2025 earnings, with adjusted earnings per share (EPS) of $1.09, surpassing the consensus estimate of $1.07. However, the company's revenue of $10.36 billion fell short of the expected $10.4 billion. Despite the revenue miss, Abbott reaffirmed its full-year guidance, projecting adjusted EPS for 2025 to be between $5.05 and $5.25, compared to the consensus of $5.15.
Read more
13 posts • OpenAI (o3)
Published
Texas Governor Greg Abbott on Friday signed 306 measures sent to him by the Legislature, capping a flurry of end-of-session activity ahead of Sunday’s deadline to act on remaining bills. His office designated 15 of the newly enacted laws as “critical.”
Among the measures is House Bill 3441, which empowers the state and consumers to sue pharmaceutical companies over deceptive advertising carried in Texas. Abbott earlier this month also approved the creation of the Texas Cyber Command, a new unit charged with protecting the state’s infrastructure from cyberattacks.
Read more
This month, Governor @GregAbbott_TX signed the Texas Cyber Command into law. The Texas Cyber Command will lead the charge to defend Texas’ critical infrastructure from hostile cybersecurity threats.
Featured story, from @KitOConnell: Tomorrow is the deadline for Governor Greg Abbott to sign, veto or let SB 3 become law automatically. One estimate suggests over 50,000 jobs and billions in income are on the line.
Abbott hinted a special session may be needed because the Legislature didn’t pass a ban on cities, counties and school districts hiring lobbyists with taxpayer money to represent them at the...
All Senate Democrats voted against the bill. They support TAXPAYER-FUNDED LOBBYING. All Texas House Republicans should vote for the bill if a special session is called.
And...@GregAbbott_TX just signed HB 3441 into law! It holds BIG PHARMA accountable if they advertise in Texas!! Thank you, Gov!💪💪💪
5 posts • GPT (4.1 mini)
Published
The World Health Organization (WHO) has approved new guidelines regulating the digital marketing of infant formula and other breast milk substitutes. This initiative, led by Brazil and supported by 20 countries, aims to ensure the appropriate use of products targeted at children and to protect parents and babies from misleading online advertisements. The agreement was reached during the 78th World Health Assembly (WHA78), where member countries also endorsed World Prematurity Day as an official WHO health campaign to emphasize the importance of prevention and expanded lifesaving healthcare for premature babies. The expansion of the International Code of Marketing of Breast-milk Substitutes to include digital marketing represents a significant policy advancement in public health efforts for infant nutrition.
9 posts • GPT (4.1 mini)
Published
Abbott Laboratories announced plans to invest $500 million in expanding its U.S. manufacturing capacity amid looming tariffs on medical devices and diagnostics. The company will build two new manufacturing plants located in Illinois and Texas. This expansion is expected to create up to 200 new jobs, particularly in the northern suburbs of Chicago. Despite the anticipated impact of tariffs, which Abbott estimates could reduce earnings by a few hundred million dollars, the company maintained its annual profit forecast. Abbott's investment reflects a strategic response to the evolving trade environment affecting the medical device industry.
25 posts • Grok (2)
Published
Abbott Laboratories reported its first-quarter 2025 earnings, with adjusted earnings per share (EPS) of $1.09, surpassing the consensus estimate of $1.07. However, the company's revenue of $10.36 billion fell short of the expected $10.4 billion. Despite the revenue miss, Abbott reaffirmed its full-year guidance, projecting adjusted EPS for 2025 to be between $5.05 and $5.25, compared to the consensus of $5.15.
Read more